CoChat

Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF

Guba, Markus, Yezhelyev, Maksim, Eichhorn, Martin E., Schmid, Gerald, Ischenko, Ivan, Papyan, Armine, Graeb, Christian, Seeliger, Hendrik, Geissler, Edward K., Jauch, Karl-Walter, Bruns, Christiane J. · 2005 · Blood
Cited by 127

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Therapeutic strategies that target and disrupt the already-formed vessel networks of growing tumors are actively pursued. The goal of these approaches is to induce a rapid shutdown of the vascular function of the tumor so that blood flow is arrested and tumor cell death occurs. Here we show that the mammalian target of rapamycin (mTOR) inhibitor rapamycin, when administered to tumor-bearing mice, selectively induced extensive local microthrombosis of the tumor microvasculature. Importantly, rapamycin administration had no detectable effect on the peritumoral or normal tissue. Intravital microscopy analysis of tumors implanted into skinfold chambers revealed that rapamycin led to a specific shutdown of initially patent tumor vessels. In human umbilical vein endothelial cells vascular endothelial growth factor (VEGF)–induced tissue factor expression was strongly enhanced by rapamycin. We further show by Western blot analysis that rapamycin interferes with a negative feedback mechanism controlling this pathologic VEGF-mediated tissue factor expression. This thrombogenic alteration of the endothelial cells was confirmed in a one-step coagulation assay. The circumstance that VEGF is up-regulated in most tumors may explain the remarkable selectivity of tumor vessel thrombosis under rapamycin therapy. Taken together, these data suggest that rapamycin, besides its known antiangiogenic properties, has a strong tumor-specific, antivascular effect in tumors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2004-09-3540

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 127

Metadata

Authors
Guba, M., Yezhelyev, M., Eichhorn, M. E., Schmid, G., Ischenko, I., Papyan, A., Graeb, C., Seeliger, H., Geissler, E. K., Jauch, K.-W., & Bruns, C. J.
Venue
Blood
Published
2005-06-01
Volume
105
Issue
11
Pages
4463-4469
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2130348457
Cited by
127
References
1
FWCI
5.07
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF. https://app.cochat.ai/papers/10.1182/blood-2004-09-3540
The paper
Guba, M., Yezhelyev, M., Eichhorn, M. E., Schmid, G., Ischenko, I., Papyan, A., Graeb, C., Seeliger, H., Geissler, E. K., Jauch, K.-W., & Bruns, C. J. (2005). Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF. Blood. https://doi.org/10.1182/blood-2004-09-3540

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.